(17:12 GMT) Unicycive Therapeutics Price Target Maintained With a $22.00/Share by B. Riley Securities
Dow Jones Newswires
Unicycive Therapeutics Is Maintained at Buy by B. Riley Securities
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:UNCY
- Language
- English